What is Lark?
Headquartered in Mountain View, California, Lark operates at the intersection of technology and healthcare, delivering virtual care through a sophisticated combination of AI coaching, smart devices, and tele-monitoring. The company aims to revolutionize patient engagement and chronic disease management by providing personalized, accessible, and data-driven health interventions. Lark's platform is designed to empower individuals to take control of their health journeys, offering continuous support and insights to improve outcomes.
How much funding has Lark raised?
Lark has raised a total of $198.2M across 8 funding rounds:
Unspecified
$1M
Series A
$3M
Private Equity
$3.1M
Series B
$20M
Multiple Rounds
$71M
Series D
$100M
Unspecified (2011): $1M with participation from Lightspeed Venture Partners
Series A (2013): $3M, investors not publicly disclosed
Private Equity (2013): $3.1M supported by Fenox Venture Capital
Series B (2017): $20M, investors not publicly disclosed
Debt (2020): $1M backed by PPP
Series C (2020): $55M with participation from King River Capital Pty Ltd
Debt (2020): $15M led by Trinity Capital and Bridge Bank.
Series D (2021): $100M supported by Franklin Templeton, Deerfield, PFM Health Sciences, and King River Capital
Key Investors in Lark
Franklin Templeton
Franklin Templeton is a global investment management organization known for its diverse asset classes and long history in the financial markets. They provide investment expertise and solutions to clients worldwide.
Deerfield
Deerfield Management is an investment firm dedicated to advancing healthcare through strategic investments, intelligence, and philanthropic initiatives, focusing on innovation across the healthcare ecosystem.
King River Capital
King River Capital is a venture capital firm that invests in high-growth technology businesses, offering flexible capital and strategic advice to support founders globally.
What's next for Lark?
With the infusion of new capital, Lark is poised to accelerate its strategic initiatives. The company is likely to focus on enhancing its AI capabilities, expanding its suite of smart devices, and broadening its tele-monitoring services. Further investment may also be directed towards strategic partnerships within the healthcare ecosystem, expanding its market reach, and potentially exploring new therapeutic areas. The enterprise-level funding suggests a focus on scaling operations and solidifying its position as a leader in the digital health landscape.
See full Lark company page
